February 1st, 2008 - Volume 47 - Issue 2 - Contributor Index

Alphabetical Search
I
Q
U
X

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):161-167, February 1st, 2008.

Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral...

Selinger-Leneman, Hana; Matheron, Sophie; Mahamat, Aba; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):206-211, February 1st, 2008.

No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial

Bollen, Liesbeth JM; Blanchard, Kelly; Kilmarx, Peter H; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):253-257, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Author:
Bini, Teresa MD

No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial

Bollen, Liesbeth JM; Blanchard, Kelly; Kilmarx, Peter H; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):253-257, February 1st, 2008.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1st, 2008.

No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial

Bollen, Liesbeth JM; Blanchard, Kelly; Kilmarx, Peter H; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):253-257, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial

Bollen, Liesbeth JM; Blanchard, Kelly; Kilmarx, Peter H; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):253-257, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial

Bollen, Liesbeth JM; Blanchard, Kelly; Kilmarx, Peter H; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):253-257, February 1st, 2008.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1st, 2008.

Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral...

Selinger-Leneman, Hana; Matheron, Sophie; Mahamat, Aba; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):206-211, February 1st, 2008.

Author:
Cotten, Paul
Author:
Coye, Frank MA

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):161-167, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):161-167, February 1st, 2008.

Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral...

Selinger-Leneman, Hana; Matheron, Sophie; Mahamat, Aba; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):206-211, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1st, 2008.

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):161-167, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Author:
Joy, Tisha MD

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

No Increase in Cervicovaginal Proinflammatory Cytokines After Carraguard Use in a Placebo-Controlled Randomized Clinical Trial

Bollen, Liesbeth JM; Blanchard, Kelly; Kilmarx, Peter H; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):253-257, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):161-167, February 1st, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1st, 2008.

Author:
Lo, Janet MD
Author:
Mahamat, Aba MD

Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral...

Selinger-Leneman, Hana; Matheron, Sophie; Mahamat, Aba; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):206-211, February 1st, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1st, 2008.

Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral...

Selinger-Leneman, Hana; Matheron, Sophie; Mahamat, Aba; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):206-211, February 1st, 2008.

HIV Incidence Among Men Diagnosed With Early Syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005

Buchacz, Kate; Klausner, Jeffrey D; Kerndt, Peter R; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):234-240, February 1st, 2008.

1 2 Next